Meng Lin
Optometrist · Berkeley, CANPI 1396180600
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $98,378 of the $99,083 with a category attached, or 99.3%. Johnson & Johnson Vision Care, Inc. accounts for 99.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $98,430 and has fallen 99.9% since, to $93 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $6605.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$98K
- Alcon$328
- Tarsus Pharmaceuticals, Inc.$222
- Oyster Point Pharma, Inc.$95
- Regeneron$33
- Coopervision Inc.$27
Across 147 payments — averaging $46,560 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coopervision Inc.$5.7M
- Coopersurgical, Inc.$534K
- Johnson & Johnson Vision Care, Inc.$278K
- Alcon Research LLC$252K
- Biotissue Holdings Inc.$36K
What the payments were for
- Consulting fees$98,37899%
- Food & beverage$7051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 2 | $98,378 |
| Alcon | 6 | $328 |
| Tarsus Pharmaceuticals, Inc. | 3 | $222 |
| Oyster Point Pharma, Inc. | 2 | $95 |
| Regeneron | 1 | $33 |
| Coopervision Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$98,378
How this compares
$99,083 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 12 | $2,902 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Berkeley
- Tara Pahlevan-ChaleshtariBerkeley$107K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.